Abercrombie & Fitch Co. Beats Estimates and Raises Guidance
Abercrombie & Fitch Co. exceeds expectations with strong Q2 results, including impressive sales growth and an upgraded outlook. Significant stock mark...
- Wednesday, October 16, 2024
News
Marks & Spencer Group to Rejoin FTSE 100 Index
Marks & Spencer Group is set to rejoin FTSE 100 index after a four-year absence, along with other companies. Get insights into the changes and informa...
Andrew R. Michaud
Berkshire Hathaway Inc. Cl B Stock Slips amid Poor Trading Session
Shares of Berkshire Hathaway Inc. Cl B experienced a slight decline amidst an overall negative trading day. This marks the sixth consecutive day of lo...
Andrew R. Michaud
AMC Entertainment Faces Panic on Stocktwits Platform
AMC Entertainment faces panic among investors on social platform Stocktwits, as sentiment hits all-time low. Categories: Finance, Investing, Entertain...
Andrew R. Michaud
Regeneron Secures Government Funding for Next-Generation COVID-19 Antibody
Regeneron receives significant government funding to develop next-gen COVID-19 antibody. Partnership with BARDA and commitment to research offer hope...
Andrew R. Michaud
Gem Diamonds Lowers Full-Year Guidance for Letseng Mine
Gem Diamonds lowers full-year guidance for diamonds treated at Letseng mine in Lesotho due to operational issues and electricity interruptions. Positi...
Andrew R. Michaud
Retailers and Consumer Companies See Growth
Retailers and consumer companies are seeing growth in the market, with a rise in consumer discretionary shares outweighing losses for consumer staples...
Andrew R. Michaud
Permian Resources Corp. Expands with $4.5 Billion Acquisition of Earthstone Energy Inc.
Permian Resources acquires Earthstone Energy, expanding its net acreage and strengthening its foothold in the lucrative Permian Basin. Industry expert...
Andrew R. Michaud
J&J Preliminary Proration Estimate at 23.8%: What You Need to Know
J&J announces a preliminary proration estimate of 23.8% for its exchange offer with Kenvue stock. Find out how shareholders and Kenvue stock are affec...
Andrew R. Michaud
Promising Results in Prostate Cancer Treatment Trial
Exelixis and Ipsen announce positive findings from a phase 3 clinical trial for metastatic castration-resistant prostate cancer treatment, with signif...
Andrew R. Michaud
All Rights Reserved © 2024